On June 13, 2022, the biotechnology company Thermo Fisher Scientific Inc. announced that its two new diagnostic blood tests – one for lupus and one for systemic sclerosis – were approved by the U.S.

The etiology of lupus profundus is not completely understood due to the lack of specific research on its pathogenesis, though immune complex disease may play a role as indicated by the association ...

A simple blood test could revolutionise treatment for lupus patients who do not respond to existing therapies, researchers say. Previous studies have shown that patients with treatment-resistant lupus ...